We are live on ! Find out more

499 hedge funds and large institutions have $11.5B invested in Sanofi in 2014 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 165 increasing their positions, 171 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 76

0.68% more ownership

Funds ownership: 18.38%19.06% (+0.68%)

1% less funds holding

Funds holding: 503499 (-4)

4% less repeat investments, than reductions

Existing positions increased: 165 | Existing positions reduced: 171

16% less capital invested

Capital invested by funds: $13.7B → $11.5B (-$2.18B)

29% less funds holding in top 10

Funds holding in top 10: 1410 (-4)

30% less call options, than puts

Call options by funds: $37.6M | Put options by funds: $53.5M

Holders
499
Holders Change
-4
Holders Change %
-0.8%
% of All Funds
13.25%
Holding in Top 10
10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-28.57%
% of All Funds
0.27%
New
78
Increased
165
Reduced
171
Closed
76
Calls
$37.6M
Puts
$53.5M
Net Calls
-$15.9M
Net Calls Change
-$21.1M

SNY Hedge Fund Activity: Q4 2014 in Review

499 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2014, worth a combined $11.5B — down 16% from $13.7B a quarter earlier.

Buyers outnumbered sellers: 78 funds opened new SNY positions and 76 closed out — a net gain of 2 holders — while 165 added to existing stakes and 171 trimmed.

The largest buyer was Neuberger Berman Group, adding an estimated $309M. The largest seller was Boston Partners, cutting an estimated $298M.

  • 499 institutional investors held Sanofi (SNY) as of Q4 2014, down from 503 in Q3 2014.
  • Funds reported $11.5B of Sanofi stock for Q4 2014, down 16% quarter-over-quarter.
  • 78 funds opened new Sanofi positions in Q4 2014 and 76 closed out, a net change of +2 holders.
  • The largest Sanofi buyer in Q4 2014 was Neuberger Berman Group, an estimated $309M added.
  • The largest Sanofi seller in Q4 2014 was Boston Partners, an estimated $298M sold.

Based on aggregated 13F filings for Q4 2014.